These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 21609531

  • 21. [Effect of triptolide on the development of monocrotaline-induced pulmonary hypertension in pneumonectomized rat].
    Wei L, Liu T, Liu B, Wang XM, Zhao L, Zhou TF.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):806-9. PubMed ID: 17953363
    [Abstract] [Full Text] [Related]

  • 22. Atorvastatin prevents dehydromonocrotaline-induced pulmonary hypertension in beagles.
    Chen D, Zhou D, Qian J, Chen F, Guan L, Dong L, Ge J.
    Exp Lung Res; 2012 Sep; 38(7):333-43. PubMed ID: 22888849
    [Abstract] [Full Text] [Related]

  • 23. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline].
    Zhao L, Zhou TF, Liu HM, Li M, Dou H, Tang ZH.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):463-5, 479. PubMed ID: 17593832
    [Abstract] [Full Text] [Related]

  • 24. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R, Zeballos GA, Tun H, Gewitz MH.
    Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
    [Abstract] [Full Text] [Related]

  • 25. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Zopf DA, das Neves LA, Nikula KJ, Huang J, Senese PB, Gralinski MR.
    Eur J Pharmacol; 2011 Nov 16; 670(1):195-203. PubMed ID: 21914448
    [Abstract] [Full Text] [Related]

  • 26. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P, Rakotoniaina Z, Goirand F, Rochette L, Dumas M, Lirussi F, Bardou M.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep 16; 373(6):401-14. PubMed ID: 16896805
    [Abstract] [Full Text] [Related]

  • 27. [Administrating bone marrow mesenchymal stem cells to treat the experimental pulmonary arterial hypertension in rats].
    He ZX, Wang HW, Shang F, Yan H, Yang Y.
    Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2110-5. PubMed ID: 20058614
    [Abstract] [Full Text] [Related]

  • 28. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
    Kanki-Horimoto S, Horimoto H, Mieno S, Kishida K, Watanabe F, Furuya E, Katsumata T.
    Circulation; 2006 Jul 04; 114(1 Suppl):I181-5. PubMed ID: 16820570
    [Abstract] [Full Text] [Related]

  • 29. All-trans retinoic acid in pulmonary vascular structural remodeling in rats with pulmonary hypertension induced by monocrotaline.
    Qin Y, Zhou A, Ben X, Shen J, Liang Y, Li F.
    Chin Med J (Engl); 2001 May 04; 114(5):462-5. PubMed ID: 11780404
    [Abstract] [Full Text] [Related]

  • 30. [Effects of peroxisome proliferator-activated receptor gamma ligands on monocrotaline-induced pulmonary hypertension in rats].
    Matsuda Y, Hoshikawa Y, Ameshima S, Suzuki S, Okada Y, Tabata T, Sugawara T, Matsumura Y, Kondo T.
    Nihon Kokyuki Gakkai Zasshi; 2005 May 04; 43(5):283-8. PubMed ID: 15969209
    [Abstract] [Full Text] [Related]

  • 31. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
    Gur S, Kadowitz PJ, Thammasitboon S, Lasky JA, Hellstrom WJ.
    J Androl; 2009 May 04; 30(5):495-504. PubMed ID: 19201699
    [Abstract] [Full Text] [Related]

  • 32. [Simvastatin prevents the development of pulmonary hypertension in the rats through reduction of inflammation].
    Zhang WH, Lu WX, Zhang YJ, Ji YQ, Liu CP, Li G.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 31; 89(12):855-9. PubMed ID: 19595129
    [Abstract] [Full Text] [Related]

  • 33. CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway.
    Zhang TT, Cui B, Dai DZ, Su W.
    Acta Pharmacol Sin; 2005 Nov 31; 26(11):1309-16. PubMed ID: 16225752
    [Abstract] [Full Text] [Related]

  • 34. Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.
    Neto-Ferreira R, Novaes Rocha V, da Silva Torres T, Mandarim-de-Lacerda CA, de Carvalho JJ.
    Exp Toxicol Pathol; 2011 Jul 31; 63(5):473-8. PubMed ID: 20537513
    [Abstract] [Full Text] [Related]

  • 35. [Expression of GATA6 gene in lung tissue of rat with pulmonary hypertension].
    Liu B, Liu HM, Yu L, Sun XJ, Wei L, Wang XM, Zhou TF.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov 31; 37(6):864-7, 875. PubMed ID: 17236581
    [Abstract] [Full Text] [Related]

  • 36. The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats.
    Yuyama H, Fujimori A, Sanagi M, Koakutsu A, Sudoh K, Sasamata M, Miyata K.
    Eur J Pharmacol; 2004 Aug 02; 496(1-3):129-39. PubMed ID: 15288584
    [Abstract] [Full Text] [Related]

  • 37. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
    Nakazawa H, Hori M, Ozaki H, Karaki H.
    Br J Pharmacol; 1999 Nov 02; 128(5):1098-104. PubMed ID: 10556948
    [Abstract] [Full Text] [Related]

  • 38. Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling.
    Yen CH, Leu S, Lin YC, Kao YH, Chang LT, Chua S, Fu M, Wu CJ, Sun CK, Yip HK.
    J Cardiovasc Pharmacol; 2010 Jun 02; 55(6):574-84. PubMed ID: 20224427
    [Abstract] [Full Text] [Related]

  • 39. KMUP-1 inhibits pulmonary artery proliferation by targeting serotonin receptors/transporter and NO synthase, inactivating RhoA and suppressing AKT/ERK phosphorylation.
    Chung HH, Dai ZK, Wu BN, Yeh JL, Chai CY, Chu KS, Liu CP, Chen IJ.
    Vascul Pharmacol; 2010 Jun 02; 53(5-6):239-49. PubMed ID: 20870034
    [Abstract] [Full Text] [Related]

  • 40. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP, Dai ZK, Huang CH, Yeh JL, Wu BN, Wu JR, Chen IJ.
    Kaohsiung J Med Sci; 2014 Jun 02; 30(6):267-78. PubMed ID: 24835346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.